{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:02:49Z","timestamp":1792425769178,"version":"4.5.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Use of insulin pumps, continuous glucose monitors (CGMs), and automated insulin delivery (AID) systems has increased substantially in type 1 diabetes (T1D) care. Although these technologies improve glycemic outcomes, their broader impact on patients\u2019 daily lives and psychosocial well-being remains incompletely understood.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To identify psychosocial and other emerging dimensions of contemporary diabetes technology use among adults with T1D.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This qualitative study used thematic analysis of free-text survey responses collected between August 1, 2024, and February 28, 2025, from adults (aged \u226518 years) with T1D receiving care within a single, large, academic health system in the US. Participants represented a range of ages, diabetes duration, and age at onset; most were users of CGMs and AID systems.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of 5650 individuals who were invited to participate in the study, 945 eligible patients responded to the survey and 535 (mean [range] age, 48 [18 to \u226570] years; 282 [52.8%] female) provided free-text responses regarding the impact of diabetes technology on daily life that were included in the qualitative analysis. The median (range) diabetes duration was 25 (0 to \u226531) years. Overall, 508 (95.0%) were using CGMs and 369 (69.0%) were using insulin pumps. Participants described diverse experiences with modern diabetes technology, reflecting both benefits and burdens. In addition to established psychosocial themes, several novel concerns were identified: environmental impact from device-related waste, travel-related stress due to supply logistics and inconsistent airport security procedures, distress related to premature device failures and challenges navigating manufacturer and insurance replacement processes, and apprehension about digital security. These structural and societal factors were described as meaningful contributors to overall technology experience.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this study of adults with T1D, contemporary diabetes technology affected more than glycemic control; environmental sustainability, administrative burden, travel logistics, and digital trust represented emerging dimensions of technology-dependent care. Addressing these concerns through patient-centered design, streamlined system processes, and transparent cybersecurity protections may enhance the long-term sustainability and acceptability of advanced diabetes technologies.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.24260","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:00:25Z","timestamp":1784646025000},"page":"e2624260","source":"Crossref","is-referenced-by-count":2,"title":["Contemporary Diabetes Technology and the Patient Experience"],"prefix":"10.1001","volume":"9","author":[{"given":"Estelle M.","family":"Everett","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles"},{"name":"Division of General Internal Medicine & Health Services Research, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles"},{"name":"Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Shaw","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Escobar Barrios","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannaz","family":"Moin","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles"},{"name":"Division of General Internal Medicine & Health Services Research, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles"},{"name":"Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Wisk","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine & Health Services Research, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles"},{"name":"Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"2","key":"zoi260683r1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/dia.2022.0340","article-title":"A longitudinal view of disparities in insulin pump use among youth with type 1 diabetes: the SEARCH for Diabetes in Youth Study.","volume":"25","author":"Everett","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"zoi260683r2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2337\/dc20-0257","article-title":"A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison.","volume":"44","author":"Addala","year":"2021","journal-title":"Diabetes Care"},{"issue":"5","key":"zoi260683r3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/dia.2019.0417","article-title":"The efficacy of technology in type 1 diabetes: a systematic review, network meta-analysis, and narrative synthesis.","volume":"22","author":"Pease","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"zoi260683r4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s00125-021-05648-4","article-title":"Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis.","volume":"65","author":"Teo","year":"2022","journal-title":"Diabetologia"},{"issue":"11","key":"zoi260683r5","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1001\/jamapediatrics.2025.2740","article-title":"Automated insulin delivery systems and glucose management in children and adolescents with type 1 diabetes: a systematic review and meta-analysis.","volume":"179","author":"de Visser","year":"2025","journal-title":"JAMA Pediatr"},{"key":"zoi260683r6","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0133","article-title":"DIAMOND Study Group. The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the DIAMOND randomized clinical trial.","author":"Polonsky","journal-title":"Diabetes Care"},{"key":"zoi260683r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102852","article-title":"Effect of automated insulin delivery systems on person-reported outcomes in people with diabetes: a systematic review and meta-analysis.","volume":"76","author":"Roos","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"1","key":"zoi260683r8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/19322968241276550","article-title":"Psychosocial aspects of diabetes technologies: commentary on the current status of the evidence and suggestions for future directions.","volume":"19","author":"Barnard-Kelly","year":"2025","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"zoi260683r9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0320702","article-title":"The experiences of high-risk young adults with type 1 diabetes transitioning to real-time continuous glucose monitoring - A thematic analysis.","volume":"20","author":"McKechnie","year":"2025","journal-title":"PLoS One"},{"issue":"3","key":"zoi260683r10","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1177\/17423953211023962","article-title":"Values and control in type 1 diabetes beyond glycemic outcomes: a qualitative interview study of everyday life with an insulin pump.","volume":"18","author":"Cleal","year":"2022","journal-title":"Chronic Illn"},{"issue":"4","key":"zoi260683r11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/dme.13568","article-title":"Best friend or spy: a qualitative meta-synthesis on the impact of continuous glucose monitoring on life with type 1 diabetes.","volume":"35","author":"Messer","year":"2018","journal-title":"Diabet Med"},{"issue":"7","key":"zoi260683r12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1089\/dia.2017.0007","article-title":"\u201cIt is definitely a game changer\u201d: a qualitative study of experiences with in-home overnight closed-loop technology among adults with type 1 diabetes.","volume":"19","author":"Hendrieckx","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"zoi260683r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.109876","article-title":"\u201cNo-one realises what we go through as Type 1s\u201d: a qualitative photo-elicitation study on coping with diabetes.","volume":"187","author":"Nettleton","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"19-20","key":"zoi260683r14","doi-asserted-by":"publisher","first-page":"7483","DOI":"10.1111\/jocn.16808","article-title":"Continuous glucose monitoring with data sharing in older adults: a qualitative study.","volume":"32","author":"Allen","year":"2023","journal-title":"J Clin Nurs"},{"issue":"8","key":"zoi260683r15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jcjd.2021.02.006","article-title":"Real-world patient experience of long-term hybrid closed-loop insulin pump use.","volume":"45","author":"Wang","year":"2021","journal-title":"Can J Diabetes"},{"issue":"6","key":"zoi260683r16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jpepsy\/jsae022","article-title":"Parent, child, and adolescent lived experience using the insulin-only iLet Bionic Pancreas.","volume":"49","author":"Howard","year":"2024","journal-title":"J Pediatr Psychol"},{"issue":"7","key":"zoi260683r17","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14828","article-title":"Parents\u2019 experiences of using remote monitoring technology to manage type 1 diabetes in very young children during a clinical trial: qualitative study.","volume":"39","author":"Hart","year":"2022","journal-title":"Diabet Med"},{"issue":"4","key":"zoi260683r18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1177\/1742395320985924","article-title":"Adolescents\u2019 and their parents\u2019 experiences of using a closed-loop system to manage type 1 diabetes in everyday life: qualitative study.","volume":"18","author":"Rankin","year":"2022","journal-title":"Chronic Illn"},{"issue":"4","key":"zoi260683r19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1037\/fsh0000485","article-title":"You, me, and diabetes: intimacy and technology among adults with T1D and their partners.","volume":"38","author":"Garza","year":"2020","journal-title":"Fam Syst Health"},{"issue":"1","key":"zoi260683r20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12902-018-0239-1","article-title":"Patients\u2019 and caregivers\u2019 experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study.","volume":"18","author":"Lawton","year":"2018","journal-title":"BMC Endocr Disord"},{"key":"zoi260683r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.162627","article-title":"Contribution of plastic and microplastic to global climate change and their conjoining impacts on the environment - A review.","volume":"875","author":"Sharma","year":"2023","journal-title":"Sci Total Environ"},{"issue":"48","key":"zoi260683r22","doi-asserted-by":"publisher","first-page":"40761","DOI":"10.1039\/D5RA05845G","article-title":"Toxic threats from plastic waste: human health impacts, challenges, and policy solutions.","volume":"15","author":"Abahussain","year":"2025","journal-title":"RSC Adv"},{"key":"zoi260683r23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.scitotenv.2016.05.084","article-title":"Plastic waste in the marine environment: A review of sources, occurrence and effects.","volume":"566-567","author":"Li","year":"2016","journal-title":"Sci Total Environ"},{"issue":"2","key":"zoi260683r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanplh.2025.101418","article-title":"Interventions to reduce greenhouse gas emissions from health-system solid waste: a systematic review.","volume":"10","author":"McGushin","year":"2026","journal-title":"Lancet Planet Health"},{"key":"zoi260683r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2021.126724","article-title":"Mapping healthcare waste management research: Past evolution, current challenges, and future perspectives towards a circular economy transition.","volume":"422","author":"Ranjbari","year":"2022","journal-title":"J Hazard Mater"},{"issue":"Pt 1","key":"zoi260683r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2022.114434","article-title":"A review on enhanced microplastics derived from biomedical waste during the COVID-19 pandemic with its toxicity, health risks, and biomarkers.","volume":"216","author":"Masud","year":"2023","journal-title":"Environ Res"},{"issue":"12","key":"zoi260683r27","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.2337\/dci22-0018","article-title":"Automated insulin delivery: benefits, challenges, and recommendations. a consensus report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.","volume":"45","author":"Sherr","year":"2022","journal-title":"Diabetes Care"},{"key":"zoi260683r28","doi-asserted-by":"publisher","DOI":"10.2337\/db25-317-OR","article-title":"317-OR: causes and consequence of diabetes supply distress\u2014qualitative analysis of T1D exchange survey responses.","author":"Welch","journal-title":"Diabetes"},{"key":"zoi260683r29","doi-asserted-by":"publisher","DOI":"10.2337\/db24-1936-LB","article-title":"1936-LB: the challenge of obtaining diabetes technology supplies in adults with type 1 diabetes.","author":"Welch","journal-title":"Diabetes"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2851862\/everett_2026_oi_260683_1784056155.58153.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:00:26Z","timestamp":1784646026000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2851862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.24260","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}